Back
AtriCure Vs. Viking Therapeutics Industry Stock Comparison
Buy
60
ATRC
AtriCure
Last Price:
$39.53
Seasonality Move:
-4.34%
Sell
11
VKTX
Viking Therapeutics
Last Price:
$34.05
Seasonality Move:
24.3%
Sell
11
Viking Therapeutics (VKTX)
is a Sell
Is Viking Therapeutics a Buy, Sell or Hold?
-
The current Viking Therapeutics [VKTX] share price is $32.87. The Score for VKTX is 11, which is 78% below its historic median score of 50, and infers higher risk than normal.
-
VKTX is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
VKTX Stock Price Chart
What is Viking Therapeutics's stock price today?
-
The Viking Therapeutics share price today is $32.87Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VKTX is experiencing slight buying pressure.
ATRC Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.37 | Buy |
Relative Strength Index (14 RSI): | 72.71 | Buy |
Chaikin Money Flow: | 500463 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (29.94 - 35.44) | Buy |
Bollinger Bands (100): | (27.43 - 35.13) | Buy |
VKTX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -4.06 | Sell |
Relative Strength Index (14 RSI): | 26.61 | Sell |
Chaikin Money Flow: | 2653987 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (36.17 - 44.89) | Sell |
Bollinger Bands (100): | (44.83 - 66.97) | Sell |
ATRC Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 35.86 | Buy |
20-day SMA: | 32.97 | Buy |
50-day SMA: | 34.26 | Buy |
200-day SMA: | 27.1 | Buy |
8-day EMA: | 36.47 | Buy |
20-day EMA: | 34.42 | Buy |
50-day EMA: | 33.19 | Buy |
200-day EMA: | 30.69 | Buy |
VKTX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 35.71 | Sell |
20-day SMA: | 39.31 | Sell |
50-day SMA: | 47.37 | Sell |
200-day SMA: | 58.83 | Sell |
8-day EMA: | 35.29 | Sell |
20-day EMA: | 39.15 | Sell |
50-day EMA: | 46.07 | Sell |
200-day EMA: | 51.8 | Sell |
AtriCure Earnings Growth & ATRC Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.11 per share, and an increase next year of $0.20 per share.
Viking Therapeutics Earnings Growth & VKTX Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.45 per share, and a decrease next year of $0.30 per share.
AtriCure Technical Analysis
Jan 6 | Jan 7 | Jan 8 | Jan 10 | Jan 13 | Jan 14 | Jan 15 | Jan 16 | Jan 17 | Jan 21 | |
---|---|---|---|---|---|---|---|---|---|---|
Jan | ||||||||||
06 | 07 | 08 | 10 | 13 | 14 | 15 | 16 | 17 | 21 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Viking Therapeutics Technical Analysis
Jan 6 | Jan 7 | Jan 8 | Jan 10 | Jan 13 | Jan 14 | Jan 15 | Jan 16 | Jan 17 | Jan 21 | |
---|---|---|---|---|---|---|---|---|---|---|
Jan | ||||||||||
06 | 07 | 08 | 10 | 13 | 14 | 15 | 16 | 17 | 21 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |